SHUKRA PHARMACEUTICALS
Back to Cashflow Statement
|
SHUKRA PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-4.52 Cr | ₹12 Cr | ₹4.94 Cr | ₹-6.68 Cr | ₹1.74 Cr |
What is the latest Cash Flow from Financing Activities ratio of SHUKRA PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-4.52 Cr |
| Mar2024 | ₹12 Cr |
| Mar2023 | ₹4.94 Cr |
| Mar2022 | ₹-6.68 Cr |
| Mar2021 | ₹1.74 Cr |
How is Cash Flow from Financing Activities of SHUKRA PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-4.52 Cr | Negative | |
| Mar2024 | ₹12 Cr | 151.06 | |
| Mar2023 | ₹4.94 Cr | Positive | |
| Mar2022 | ₹-6.68 Cr | Negative | |
| Mar2021 | ₹1.74 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹1,428.4 Cr | -6.5% | -13% | 66% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹388,680.0 Cr | -2.9% | -8.9% | -3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,817.0 Cr | 1.2% | 4.2% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,297.0 Cr | -1.7% | -3.6% | 27.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,828.0 Cr | 6.8% | 1.3% | 13.2% | Stock Analytics | |
| CIPLA | ₹104,588.0 Cr | 5.4% | 3.1% | -13.6% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | -6.5% |
-13% |
66% |
| SENSEX | -2.3% |
3.3% |
-2.4% |
You may also like the below Video Courses